N. P. Ogarev's Mordovia State University is located in the city of Saransk in the Republic of Mordovia, Russia. The university offers bachelor's and master's degrees in various academic fields.

During the past decade, Mordovia State University conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mordovia State University" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Promomed, LLC" with 2 trials sponsored, "Apollomics Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Elevar Therapeutics" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mordovia State University" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Atlant Clinical Ltd." with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mordovia State University" are "Non-Small Cell Lung Cancer" (3 trials), "COVID-19" (2 trials), "Gastric Cancer" (2 trials), "NSCLC" (2 trials) and "Acute Respiratory Infection" (1 trials). Many other conditions were trialed in "Mordovia State University" in a lesser frequency.

Most popular intervention types in "Mordovia State University" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials), "Placebo" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mordovia State University" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Mordovia State University". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mordovia State University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mordovia State University, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".